← Back to Search

Behavioural Intervention

Questionnaire Formats for ADHD

N/A
Recruiting
Led By Roni Kraut
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
19 - 65 years old
Be older than 18 years old
Must not have
Patients who do not have the capacity to complete the form (e.g., cognitive impairment, unable to read English, unable to use a computer)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, estimated to be 2 months
Awards & highlights

Summary

This trial focuses on the use of a questionnaire called the Adult ADHD Self-Report Scale in family medicine clinics to identify ADHD in adults. However, the questionnaire format may make it easy for patients to figure

Who is the study for?
This trial is for individuals who are being screened for Attention Deficit Hyperactivity Disorder (ADHD) in family medicine clinics. The eligibility criteria details are not provided, so it's unclear who exactly can or cannot participate.
What is being tested?
The study is testing different formats of the Adult ADHD Self-Report Scale (ASRS). It compares three versions: one without shading and with grouping, another with shading but no grouping, and a third without either feature.
What are the potential side effects?
Since this trial involves only changes to the format of a questionnaire and does not include medication or medical procedures, there are no direct physical side effects associated with participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 19 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am able to complete forms and do not have cognitive impairments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, estimated to be 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, estimated to be 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Screen positive rate

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: ASRS without shading and without groupingExperimental Treatment1 Intervention
These participants will receive the ASRS form that does not have shading for the screen positive response options and has the questions ungrouped (ie, the headings "Part A" and "Part B" are removed).
Group II: ASRS without shading and with groupingExperimental Treatment1 Intervention
These participants will receive the ASRS form that does not have shading for the screen positive response options and has the questions grouped (ie, the headings "Part A" and "Part B" will remain on the form).
Group III: ASRS with shading and without groupingExperimental Treatment1 Intervention
These participants will receive the ASRS form that has the screen positive response options shaded and has the questions ungrouped (ie, the headings "Part A" and "Part B" are removed).
Group IV: Standard ASRS: with shading and with groupingActive Control1 Intervention
These participants will receive the standard ASRS form. This form has the positive response options for each question shaded and has the questions grouped (ie, the headings "Part A" and "Part B" will remain on the form).

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
913 Previous Clinical Trials
388,933 Total Patients Enrolled
4 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
666 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Roni KrautPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
450 Total Patients Enrolled
~1000 spots leftby Sep 2025